Vivimed Labs Ltd. (VIVIMEDLAB)의 가격은 얼마입니까?

Vivimed Labs Ltd. (VIVIMEDLAB)의 가격은 $0.05418616입니다.

Vivimed Labs Ltd. (VIVIMEDLAB)의 시가 총액은 무엇입니까?

Vivimed Labs Ltd. (VIVIMEDLAB)의 시가 총액은 $4.49M입니다.

Vivimed Labs Ltd. (VIVIMEDLAB) PER

Established in 1988 and headquartered in Hyderabad, India, Vivimed Labs Limited, along with its associated entities, is an international manufacturer and supplier of diverse products, including active pharmaceutical ingredients (APIs), finished drug formulations, specialized chemicals, and consumer-branded remedies. Its global presence extends across markets such as India, Mexico, Spain, and Hungary, among others. The company's operations are divided into two core segments: the Pharmaceutical Business and the Specialty Chemicals Business. Within its Pharmaceutical division, Vivimed Labs supplies APIs and crucial intermediates to both generic and ethical pharmaceutical companies. It also develops and markets proprietary branded formulations catering to therapeutic areas like ophthalmology, nutraceuticals, dermatology, and pain relief. Additionally, it provides contract manufacturing services for a variety of dosage forms, including capsules, tablets, syrups, liquids, nasal sprays, and ointments. A notable product is Favulous, manufactured for the treatment of mild to moderate COVID-19 cases. The Specialty Chemicals segment boasts a broad portfolio. This includes Jarocol-branded hair dye intermediates essential for permanent, semi-permanent, and temporary hair coloring systems, alongside oxidation dye couplers, bases, and direct and basic dyes. It also produces Reversacol-branded photochromic dyes and antimicrobial agents utilized in applications ranging from plastic additives to antibacterial handwashes. Furthermore, the company manufactures photographic chemicals, such as black and white developers and antifog additives, for medical and industrial X-ray imaging, consumer photography, and graphic arts litho-plate production. Collectively, Vivimed Labs' offerings find extensive application in the home, personal, and industrial care sectors.

연도	P/E 비율	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

P/E 비율

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	P/E 비율	P/E 비율 차이	국가
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	38.29	-	IN

회사

P/E 비율

P/E 비율 차이

국가